Echo Street Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-26,018
Closed -$771K 172
2023
Q3
$771K Buy
+26,018
New +$915K 0.01% 182
2023
Q1
Sell
-35,486
Closed -$965K 533
2022
Q4
$965K Buy
+35,486
New +$1.62M 0.01% 160
2022
Q3
Sell
-17,147
Closed -$692K 610
2022
Q2
$692K Buy
+17,147
New +$850K 0.01% 235
2021
Q3
Sell
-5,541
Closed -$688K 675
2021
Q2
$688K Buy
5,541
+4,103
+285% +$552K 0.01% 276
2021
Q1
$220K Sell
1,438
-4,615
-76% -$697K ﹤0.01% 473
2020
Q4
$780K Buy
+6,053
New +$696K 0.01% 198

Other funds holding GH

Echo Street Capital Management's GH Position: Q4 2023 in Review

Echo Street Capital Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 26,018 shares — an estimated $771K sold.

Echo Street Capital Management first reported a position in GH in Q4 2020 and held it in 6 quarters. The position peaked at $965K in Q4 2022. 295 funds tracked by Wall St. Rank hold GH as of Q4 2023.

  • Echo Street Capital Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 26,018 Guardant Health shares in Q4 2023, an estimated $771K.
  • Echo Street Capital Management first reported a position in Guardant Health in Q4 2020 and held it in 6 quarters.
  • Echo Street Capital Management's Guardant Health position peaked at $965K in Q4 2022.
  • 295 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.